Armin Schulz
Born in Mönchengladbach, he studied business administration in the Netherlands. In the course of his studies he came into contact with the stock exchange for the first time. He has more than 25 years of experience in stock market business.
After graduating, he worked as an IT consultant for a listed company before becoming self-employed, during which time he worked for various DAX-listed companies and a large Swiss insurance company, among others.
Since 2009, he has been exclusively involved in the capital markets, where he was able to gain experience as a day and swing trader, in investor relations and at board level. He was able to live out his passion for numbers in the controlling department of a securities trading house.
For him, fundamental analysis paired with the correct reading of the price action of a market provides the basis for successful trading.
Commented by Armin Schulz
Commented by Armin Schulz on March 6th, 2024 | 07:00 CET
Cardiol Therapeutics is on the upswing - When will BioNTech and Evotec follow suit?
In the world of biotechnology, the stock market often resembles a rollercoaster ride where investors and companies need to be firmly strapped in. The volatility of biotech companies can include dizzying highs and lows driven by the research and development of new medical treatments and therapies. A single positive report of clinical trial results or regulatory approval of a breakthrough drug can send a company's share price soaring, sending investors and companies into euphoria overnight. This happened recently with Cardiol Therapeutics. When can Evotec and BioNTech announce a success?
Read
Commented by Armin Schulz on March 4th, 2024 | 07:15 CET
Kraken Energy, RWE, Plug Power - Is Germany reconsidering its nuclear phase-out?
Calls for a U-turn on the nuclear energy issue are getting louder in Germany. Above all, the AfD, the CDU/CSU, and the FDP, as members of the traffic light government, are calling for a resumption of nuclear power generation. In Europe, Germany's energy policy has already caused considerable head-shaking. Nuclear power can shoulder the base load, does not produce CO2 emissions and is cheaper and less volatile than renewable energies. Many countries agree on one thing: we need to move away from fossil fuels. In the Czech Republic, plans are underway to build 4 new nuclear power plants, and in Poland, the Netherlands and Sweden, there is no longer interest in phasing out nuclear power. It will be interesting to see how Germany's struggle for energy develops.
Read
Commented by Armin Schulz on February 28th, 2024 | 07:15 CET
Varta Thriller! Altech Advanced Materials, BYD work on the electrification of the future
While production at Varta is at a standstill following a cyber attack, the wave of electrification is rolling inexorably through our society, changing how we generate, store and utilize energy. Innovations are needed here, especially in energy storage from renewable sources and the further development of batteries for use in electric vehicles. Advances in electric vehicles and the increasing use of electrical energy are paving the way towards the future. Intensive research is currently being carried out on technologies that will increase both the effectiveness and capacity of battery systems. Altech Advanced Materials and BYD stand out here.
Read
Commented by Armin Schulz on February 26th, 2024 | 07:00 CET
Plug Power, First Hydrogen, Daimler Truck - Hydrogen: the game changer in transportation
The rapid development of electromobility has undoubtedly brought many advantages. However, there are some questions regarding its suitability for use in commercial transportation. The issues concerning the weight of the batteries, the long recharging time, and the limited range cannot be ignored. In view of these facts, it is questionable whether electric vehicles can completely replace diesel fuel in commercial transportation. There is a need for further technological advances, such as hydrogen propulsion. Although hydrogen has not yet received the same level of attention as electric vehicles, its potential suggests that it can solve the current problems.
Read
Commented by Armin Schulz on February 21st, 2024 | 07:30 CET
Barrick Gold, Desert Gold, Renk - Golden times everywhere?
The world is full of economic uncertainty and geopolitical tensions. These are ideal conditions for gold, which is still considered a safe haven. There are now several factors that point to a sustained upswing in gold prices. One factor is the increased involvement of central banks, which are increasing their reserves to an extent not seen for decades. Another factor is the discussion within the BRICS nations about introducing a new currency backed by gold as a counterweight to the dominant US dollar. Therefore, today, we look at two gold companies and shed light on Renk, a representative of the defense industry, which is also experiencing golden times.
Read
Commented by Armin Schulz on February 20th, 2024 | 07:45 CET
ThyssenKrupp Nucera, dynaCERT, Plug Power - Hydrogen Stocks: Buy or Wait?
In light of global efforts to reduce CO2 emissions, hydrogen is coming into focus as a promising alternative in the transportation sector. The quick refueling times and greater ranges of hydrogen are particularly enticing, potentially solving the challenges of electromobility. Fleet operators must also become active, especially in response to the savings demanded by the government. Despite the clear potential for more sustainable mobility, hydrogen companies currently find themselves in a challenging situation on the stock markets, plagued by market uncertainties and the challenges of a nascent technology. Today, we look at three companies whose business is based on hydrogen.
Read
Commented by Armin Schulz on February 19th, 2024 | 07:15 CET
Defense Metals, BYD, Rheinmetall - No high-tech technology without this resource
In today's technology-driven world, rare earths have become indispensable building blocks for modern high-tech applications. From high-performance electric vehicles, which promise environmentally conscious mobility, to sophisticated equipment in the defense industry, whose importance increases in times of geopolitical tensions - rare earths are everywhere. These elements, often invisible yet crucial, enable the functionality and efficiency of devices and systems used in our daily lives, such as smartphones. Rare earths have become a silent backbone of technological innovation and security policy, whose availability and control can play a decisive role in economic success and strategic superiority.
Read
Commented by Armin Schulz on February 14th, 2024 | 07:30 CET
Nel ASA, Klimat X Developments, Nordex - Climate Neutral: The Business Booster
In a world that is increasingly scrutinizing the ecological footprint of business ventures, companies that actively integrate measures to achieve climate neutrality into their business processes are increasingly coming into focus. Such proactive companies can gain a significant competitive advantage in the current environment. It is not only end consumers who are increasingly paying attention to the climate neutrality of companies but also the companies themselves. Being climate-neutral enhances the value of one's brand, providing an additional selling point, and green companies receive bonus points in financing discussions. We take a look at three companies that are trying to make the world a greener place.
Read
Commented by Armin Schulz on February 13th, 2024 | 07:00 CET
TUI, Globex Mining, Palantir - Movement is possible here
Investors should have TUI, Globex Mining and Palantir on their watchlist, as they could be on the verge of movement. While TUI, as a leading tourism company, is showing signs of recovery after the pandemic, Globex Mining promises important impetus for the future of the industry and green technologies with its broad commodities portfolio. Palantir, on the other hand, known for its advanced data analytics platforms, is on the brink of significant growth opportunities in an increasingly data-rich era. In this context, movements are possible, and as an investor, one would want to be invested early. We highlight the potential of the three companies.
Read
Commented by Armin Schulz on February 12th, 2024 | 07:00 CET
MorphoSys, Defence Therapeutics, Bayer - Biotech and Pharma suddenly back in focus
Biotech ETFs have been on the rise since the end of October 2023. German biotech companies were able to raise more funds again last year. There are increasing signs that the tough times for investors in biotech and pharmaceutical companies are over. There is also growing activity on the takeover side. Most recently, the takeover bid from Novartis shifted the focus to companies in the healthcare sector. The Swiss pharmaceutical company wants to acquire MorphoSys for EUR 2.7 billion and thus fill up its oncology pipeline. We have selected three companies from the biotech and pharma sectors and examined their current situation.
Read